Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 27.04.2026 1 Am J Gastroenterol 1 Biochem Biophys Res Commun 3 BMC Cancer 2 BMC Gastroenterol 6 Endoscopy 3 Gastroenterology 3 Gut 1 Hepatology 1 Indian J Gastroenterol 2 Int J Cancer 1 J Clin Oncol 3 J Gastroenterol 1 J Gastroenterol Hepatol 4 J Hepatol 1 J Pediatr 1 J Pediatr Surg 1 Lancet 2 PLoS One 1 Radiol Imaging Cancer 4 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. HOFINGER P, Schluchter H, Semmler G, Balcar L, et al
   Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLD.
   Am J Gastroenterol. 2026 Apr 22. doi: 10.14309/ajg.0000000000004033.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. YANG X, Liu X, Wang W, Guo A, et al
   Downregulation of LANCL1 exacerbates jaundice-induced liver injury by enhancing oxidative stress and hepatocyte apoptosis.
   Biochem Biophys Res Commun. 2026;818:153803.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. SARELIN N, Kairaluoma V, Saarnio J, Kauppila JH, et al
   Tumour necrosis as a prognostic indicator in hepatocellular carcinoma.
   BMC Cancer. 2026 Apr 21. doi: 10.1186/s12885-026-16040.
   PubMed        
   
   
4. JUNG HS, Baek GO, Yoon MG, Jang SH, et al
   Systematic transcriptomic analysis of UDP-glucuronosyltransferases reveals UGT2B11 as a diagnostic and metabolic marker in hepatocellular carcinoma.
   BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-16066.
   PubMed        
   
   
5. ICHIO K, Einama T, Ohara M, Shinada H, et al
   Relationship of preoperative low muscle mass with postoperative loss of independence after hepato-biliary-pancreatic surgery in elderly patients: a single-center retrospective study.
   BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16041.
   PubMed        
   
   

   
   BMC Gastroenterol

6. AKHTAR S, Almohaid S
   Hepatocellular carcinoma risk, net survival and relative survival ratio in a high-income country of the Eastern Mediterranean Region: 2008-2020.
   BMC Gastroenterol. 2026 Apr 23. doi: 10.1186/s12876-026-04855.
   PubMed        
   
   
7. KOHRER S, Brand ML, Leidner V, Zimmer H, et al
   Exploratory longitudinal cohort study of modest bilirubin-driven biochemical liver alterations after SARS-CoV-2 infection in a selected subgroup of patients with Wilson's disease and liver cirrhosis.
   BMC Gastroenterol. 2026;26:241.
   PubMed         Abstract available
   
   

   
   Endoscopy

8. FURUTA A, Ueda K, Matsumoto K, Murakami M, et al
   Inward migration of a dedicated hepaticogastrostomy plastic stent into the bile duct after hepaticojejunostomy.
   Endoscopy. 2026;58.
   PubMed        
   
   
9. GAO P, Zhou Q, Zhou P, Li B, et al
   Endoscopic transgastric removal of a migrated intrahepatic fish bone via a cardia-lesser curvature tunnel.
   Endoscopy. 2026;58.
   PubMed        
   
   
10. KITAGAWA K, Hanatani JI, Asada S, Osaki Y, et al
    A case of gas in the stomach wall and portal vein following endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2026;58.
    PubMed        
    
    
11. NISHIKAWA T, Morii S
    Endoscopic ultrasound-guided hepaticogastrostomy with antegrade and bridging stenting for diffusely extending cholangiocarcinoma.
    Endoscopy. 2026;58.
    PubMed        
    
    
12. UBA Y, Hara K, Okuno N, Haba S, et al
    Stent-free biliary bypass by endoscopic ultrasound-guided choledochoduodenostomy for benign common hepatic duct stricture.
    Endoscopy. 2026;58.
    PubMed        
    
    
13. SAGAMI R, Hiroshima Y, Asahina F, Azuma Y, et al
    Misdeployment of the metal stent during direct endoscopic ultrasound-guided hepaticogastrostomy without tract dilation.
    Endoscopy. 2026;58.
    PubMed        
    
    

    
    Gastroenterology

14. TAVAGLIONE F, Vaz J, Jamialahmadi O, Diaz LA, et al
    The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use.
    Gastroenterology. 2026;170:1033-1046.
    PubMed         Abstract available
    
    
15. RICH NE, Villanueva A, Marrero JA, Kanwal F, et al
    AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2026 Apr 15:S0016-5085(26)00243.
    PubMed         Abstract available
    
    
16. KIM A, Alligood DM, Maram L, Phelps HM, et al
    A Gut-Restricted Liver X Receptor Agonist Ameliorates Liver Injury in Experimental Short Bowel Syndrome.
    Gastroenterology. 2026;170:1017-1032.
    PubMed         Abstract available
    
    

    
    Gut

17. GAO W, Liu C
    Letter to the editor regarding: Lai, Jimmy Che-To, et al "Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease".
    Gut. 2026 Apr 21:gutjnl-2026-339053. doi: 10.1136/gutjnl-2026-339053.
    PubMed        
    
    
18. ZHANG X, Roehlen N
    CD48(+) tumour-associated macrophages: novel immunotherapeutic targets in hepatocellular carcinoma.
    Gut. 2026 Apr 21:gutjnl-2026-338840. doi: 10.1136/gutjnl-2026-338840.
    PubMed        
    
    
19. MENG XL, Lu JC, Zhang YX, Pu P, et al
    Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion.
    Gut. 2026 Apr 20:gutjnl-2025-337595. doi: 10.1136/gutjnl-2025-337595.
    PubMed         Abstract available
    
    

    
    Hepatology

20. KANWAL F, Feng Z, Hoshida Y, Chhatwal J, et al
    Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium.
    Hepatology. 2026 Apr 20. doi: 10.1097/HEP.0000000000001745.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

21. VASHISHTHA C, Bhardwaj A, Pasupuleti SSR, Prasad M, et al
    Platelet count, liver and spleen stiffness-based model reliably identifies esophageal varices needing treatment in acute-on-chronic liver failure.
    Indian J Gastroenterol. 2026 Apr 20. doi: 10.1007/s12664-025-01963.
    PubMed         Abstract available
    
    

    
    Int J Cancer

22. SONG M, Wang X, Liang J, Wang L, et al
    The CXCL12-CXCR4/CXCR7 axis as a therapeutic target in liver cancer: Enhancing immune evasion and the future of combination therapies.
    Int J Cancer. 2026;158:3065-3079.
    PubMed         Abstract available
    
    
23. LIU J, Tang M, Xuan J, Tang T, et al
    Perioperative Targeted Immunotherapy Combined With Transarterial Chemoembolization Improves Survival in Borderline Resectable Hepatocellular Carcinoma.
    Int J Cancer. 2026 Apr 21. doi: 10.1002/ijc.70495.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

24. GELLI M, Ewald J, Tanguy ML, Passot G, et al
    Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.
    J Clin Oncol. 2026 Apr 22:JCO2501737. doi: 10.1200/JCO-25-01737.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

25. IKEHARA T, Otsu H, Tobo T, Hosoda K, et al
    Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma.
    J Gastroenterol. 2026 Apr 20. doi: 10.1007/s00535-026-02380.
    PubMed         Abstract available
    
    
26. CHI CT, Huang YH
    Optimal treatment selection for hepatocellular carcinoma in the era of immunotherapy.
    J Gastroenterol. 2026 Apr 20. doi: 10.1007/s00535-026-02411.
    PubMed         Abstract available
    
    
27. LIN C, Kang S, Zhang J, Yu W, et al
    The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma.
    J Gastroenterol. 2026 Apr 24. doi: 10.1007/s00535-026-02421.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

28. MUHAMMAD Y, Jin Y, Luo K, Bai H, et al
    Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy-A Comprehensive Review.
    J Gastroenterol Hepatol. 2026 Apr 23. doi: 10.1111/jgh.70357.
    PubMed         Abstract available
    
    

    
    J Hepatol

29. SUN Q, Ramos SG, Schwabe RF
    Beyond proliferation: YAP shapes the tumor identity and immune landscape of intrahepatic cholangiocarcinoma.
    J Hepatol. 2026 Apr 18:S0168-8278(26)00209-6. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
30. PEISELER M
    Peeling back the layers: resident Kupffer cell plasticity shapes hepatic defense lines in tuberculosis granulomas.
    J Hepatol. 2026 Apr 18:S0168-8278(26)00207-2. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
31. VAN MELKEBEKE L, Boesch M, Ostyn T, Huang W, et al
    Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis.
    J Hepatol. 2026 Apr 20:S0168-8278(26)00205-9. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
32. AGUILAR F, Lozano JJ, Claria J, Reinartz Groba SN, et al
    Corrigendum to "Maladaptive emergency granulopoiesis predicts poor outcomes in patients hospitalized with decompensated cirrhosis" [J Hepatol (2026) 749-765].
    J Hepatol. 2026 Apr 22:S0168-8278(26)00156-X. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    

    
    J Pediatr

33. STEINMAN JB, Duong N, Partida I, Bien-Aime C, et al
    Characteristics of Transient Elastography for Hepatic Steatosis and Fibrosis in Children Undergoing Liver Biopsy.
    J Pediatr. 2026 Apr 17:115107. doi: 10.1016/j.jpeds.2026.115107.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

34. ETSKOVITZ H, Chugh PV, Kim RS, Nes EK, et al
    Intestinal failure outcomes in children with small-intestinal Hirschsprung disease: A matched study.
    J Pediatr Surg. 2026;61:162886.
    PubMed         Abstract available
    
    

    
    Lancet

35. VON SETH E, Karlsen TH, Tanaka A, Ponsioen C, et al
    Primary sclerosing cholangitis.
    Lancet. 2026 Mar 20:S0140-6736(25)02582-6. doi: 10.1016/S0140-6736(25)02582.
    PubMed         Abstract available
    
    

    
    PLoS One

36. CUI K, Li X, Li Y, Li Z, et al
    The role of SPP1 in evaluating the prognosis, immune infiltration, and drug sensitivity of hepatocellular carcinoma.
    PLoS One. 2026;21:e0347842.
    PubMed         Abstract available
    
    
37. YANG J, Morhard R, Huth H, Karim B, et al
    Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver.
    PLoS One. 2026;21:e0347625.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

38. ZHANG M
    Deep Learning-based Multiple Arterial Phase MRI: A Step toward Improved Hepatocellular Carcinoma Diagnosis.
    Radiol Imaging Cancer. 2026;8:e260156.
    PubMed        
    
    

    
    Transplantation

39. KIM SM, Oh RK, Yoon YI, Choi WM, et al
    Renal Recovery Benefit of Living Versus Deceased Donor Liver Transplantation in Recipients With High Model for End-Stage Liver Disease Scores: A Propensity Score-matched Study.
    Transplantation. 2026 Feb 16. doi: 10.1097/TP.0000000000005656.
    PubMed         Abstract available
    
    
40. TANAKA T, Jones MP, Wehby G, Axelrod D, et al
    Impact of Model for End-stage Liver Disease Cutoffs on Liver Transplant Access in the United States: A Regression Discontinuity Design.
    Transplantation. 2026 Feb 2. doi: 10.1097/TP.0000000000005650.
    PubMed         Abstract available
    
    
41. MALUF DG, Al-Adra D, Mas VR
    Reprogramming Hepatic Resilience: BMK1 as a Cytoprotective Axis in Liver Ischemia-reperfusion Injury.
    Transplantation. 2026 Apr 21. doi: 10.1097/TP.0000000000005743.
    PubMed        
    
    
42. KROEMER A, Moris D, Nijhar K, Jia II, et al
    Expanding Pediatric Liver Transplant Options: On-pump Split Reduction With Normothermic Machine Perfusion.
    Transplantation. 2026 Mar 30. doi: 10.1097/TP.0000000000005653.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum